Skip to main content
. 2017 Dec 14;2017(12):CD009789. doi: 10.1002/14651858.CD009789.pub2

Drobnic 2014.

Methods Randomised controlled trial (parallel design)
Participants Setting: laboratory, Spain
n = 20 male, healthy, moderately exercising (regular aerobic exercise for at least 4 hours per week), non‐smoking with no injury
Mean age 38.1 (SD 11.1) years in placebo group (n = 10)
Mean age 32.7 (SD 12.3) years in curcumin group (n = 9)
Interventions Intervention
Curcumin given as the Phytosome delivery system (Meriva) 1 g twice daily corresponding to 200 mg curcumin twice daily
Placebo
Matched capsules
Duration
5 days ‐ supplements taken 2 days prior to running
Outcomes PRIMARY
Delayed onset muscle soreness lower limbs when descending and climbing stairs (4‐point visual analogue scale: 0 is "no pain" and 4 is "disabling pain"). Scores were a sum of 8 sites (anterior right thigh, posterior right thigh, anterior right leg, posterior right leg, anterior left thigh, posterior left thigh, anterior left leg, posterior left leg)
Exercise type Downhill running test on a treadmill at grade ‐10% at a constant speed (anaerobic threshold) for 45 minutes
Sources of funding Authors Stefano Togni and Fedrico are employees of Indena SpA the manufacturer of Meriva, Giovanni Appendino is a consultant to Indena SpA
Statistical analysis assistance was funded by Indena
Notes Authors were contacted to request raw data for delayed onset muscle soreness on 18 February 2016 and responded on 18 February 2016
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Randomised used computer software
Allocation concealment (selection bias) Unclear risk No details of safeguards. Although placebo‐controlled, the sports medicine physicians performing the exercise test beforehand were not blinded
Blinding of participants and personnel (performance bias) 
 All outcomes High risk "Study subjects and physicians performing the radiologic and laboratory assessments were blinded to treatment, whereas the sports medicine physicians involved in exercise testing were not."
It is not explained why the lattermost were not blinded
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk "Study subjects and physicians performing the radiologic and laboratory assessments were blinded to treatment, whereas the sports medicine physicians involved in exercise testing were not."
It is likely that the participants reporting DOMS were blinded but some uncertainty remains
Incomplete outcome data (attrition bias) 
 All outcomes Low risk 1 dropout by personal decision; 5% dropout rate
Selective reporting (reporting bias) High risk No published protocol available
All outcomes reported at all time points
Adverse effects of antioxidant supplementation were not reported
Other bias Low risk Participants were asked to refrain from using anti‐inflammatory medication and other supplements for the duration of the study
Participants were familiarised with the protocol and diet was standardised